Age-Related Development During Predictors and Clinical Neurodiagnostic Criteria of Cognitive Impairment in the General Medical Network

Background: prevalence, severity and heterogeneity of cognitive impairment in elderlies along with limited therapy options determine the relevance of the problem of timely diagnostics of cognitive disfunction. The purpose of this study is to identify a combination of the most informative patterns that allow a differentiated approach to the diagnosis of age-related cognitive impairment. Patients and methods: 213 patients were examined (99 patients 50–65 years old, 114 patients over 65 years of age) of “Federal Centre for High Medical Technologies” of Russian Ministry of Health (Kaliningrad). All patients complained for impaired mental performance, memory and attention. A neuropsychologic testing was conducted using next scales: Montreal Cognitive Assessment (MoCA), Hospital Anxiety and Depression Scale (HADS), Multidimensional Fatigue Inventory (MFI-20) and additional cognitive impairment tests. For statistical analysis, machine learning algorithms, Python programming language, and Pandas and SciPy libraries were used. Results: for patients in the 50–65 age category, high relevance was found for executive dysfunction, decreased attention span, fatigue, anxiety, and endocrine system disorders. For patients over 65 years of age, significant features were semantic aphasia, perceptual and memory impairment, hyperlipidemia, history of ischemic stroke, and obesity. A significant negative correlation for the age index was found with the parameters of depression and anxiety; a positive correlation was found with the index of physical asthenia, disorders of perception, memory and semantic processing of information. Conclusion: the results demonstrate prevalence of cognitive dysfunctions in elderly patients. The tests assessing visual perception and semantic information processing can be of interest in early degenerative cognitive impairments diagnosis in elderly age. Discriminant analysis of a wide range of age-related variables will allow to make more effective aging trajectories prediction without any time-consuming diagnostic methods.

1. Tabeeva GR. Neurocognitive aging and cognitive disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(6):160–167. (In Russ.). doi: 10.17116/jnevro2019119061160

2. McCollum L, Karlawish J. Cognitive Impairment Evaluation and Management. Med Clin North Am. 2020 Sep;104(5):807–825. doi: 10.1016/j.mcna.2020.06.007 PMID: 32773047; PMCID: PMC7416715.

3. Han F, Luo C, Lv D, Tian L, Qu C. Risk Factors Affecting Cognitive Impairment of the Elderly Aged 65 and Over: A Cross-Sectional Study. Front Aging Neurosci. 2022 Jun 16;14:903794. doi: 10.3389/fnagi.2022.903794 PMID: 35783132; PMCID: PMC9243469.

4. Lokshina AB, Grishina DA, Zakharov VV. Vascular cognitive impairment: issues of diagnosis and treatment. Neurology, Neuropsychiatry, Psychosomatics. 2023;15(2):106–113. (In Russ.). doi: 10.14412/2074-2711-2023-2-106-113

5. Custodio N, Montesinos R, Lira D, Herrera-Pérez E, Bardales Y, Valeriano-Lorenzo L. Mixed dementia: A review of the evidence. Dement Neuropsychol. 2017 Oct-Dec;11(4):364–370. doi: 10.1590/1980-57642016dn11-040005 PMID: 29354216; PMCID: PMC5769994.

6. Sidey-Gibbons JAM, Sidey-Gibbons CJ. Machine learning in medicine: a practical introduction. BMC Med Res Methodol. 2019 Mar 19;19(1):64. doi: 10.1186/s12874-019-0681-4 PMID: 30890124; PMCID: PMC6425557.

7. Qin F, Luo M, Xiong Y, Zhang N, Dai Y, Kuang W, Cen X. Prevalence and associated factors of cognitive impairment among the elderly population: A nationwide cross-sectional study in China. Front Public Health. 2022;10:1032666. doi: 10.3389/fpubh.2022.1032666 PMID: 36466480; PMCID: PMC9713248.

8. Levin OS. Predementia neurocognitive impairment in the elderly. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(9–2):10–17. (In Russ.). doi: 10.17116/jnevro201911909210

9. Ward EV, Berry CJ, Shanks DR, Moller PL, Czsiser E. Aging Predicts Decline in Explicit and Implicit Memory: A Life-Span Study. Psychol Sci. 2020 Sep;31(9):1071–1083. doi: 10.1177/0956797620927648 Epub 2020 Jul 31. PMID: 32735485; PMCID: PMC7521015.

10. McDaniel MA, Einstein GO. The neuropsychology of prospective memory in normal aging: a componential approach. Neuropsychologia. 2011 Jul; 49(8):2147–2155. doi: 10.1016/j.neuropsychologia.2010.12.029

11. Gribanov AV, Dzhos YuS, Deryabina IN, Deputat IS, Emelianova TV. An aging brain: morphofunctional aspects. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(1–2):3–7. (In Russ.). doi: 10.17116/jnevro2017117123-7

12. Teissier T, Boulanger E, Deramecourt V. Normal ageing of the brain: Histological and biological aspects. Rev Neurol (Paris). 2020 Nov;176(9):649–660. doi: 10.1016/j.neurol.2020.03.017 Epub 2020 May 14. PMID: 32418702.

13. Koo YW, Neumann DL, Ownsworth T, Shum DHK. Revisiting the Age-Prospective Memory Paradox Using Laboratory and Ecological Tasks. Front Psychol. 2021 Jun 17; 12:691752. doi: 10.3389/fpsyg.2021.691752 PMID: 34220653; PMCID: PMC8245680.

14. Weekes BSH. Aphasia in Alzheimer’s Disease and Other Dementias (ADOD): Evidence from Chinese. Am J Alzheimers Dis Other Demen. 2020 Jan-Dec; 35:1533317520949708. doi: 10.1177/1533317520949708

15. Semenova TN, Guzanova EV, Sorokina TA. Features of speech disorders and their diagnosis in patients with neurodegenerative diseases. Practical Medicine. 2019;17(3):23–27. (In Russ). doi: 10.32000/2072-1757-2019-3-23-27

16. Dmitriev M, Reverchuk I, Glavatskikh M, Khejgetyan A. Medical students’ attitudes towards mental stigmatization and its associated with own and familial psychosomatic disorders. In: E3S Web of Conferences. 2020;210:19020. EDP Sciences. doi: 10.1051/e3sconf/202021019020

17. Zuev AV, Reverchuk IV, Gontar AA. Complex therapy of psoriasis and multidisciplinary correction of maladjustment against the background of psychodermatological changes. Russian Journal of Clinical Dermatology and Venereology. 2021;20(1):50–54. (In Russ.). doi: 10.17116/klinderma20212001150